CONMED to Acquire In2Bones Global
In2Bones' product portfolio includes implants, fracture systems, biologics and related hardware to treat upper and lower extremities....
The two-year minimum clinical outcome study reported positive results for Exactech's Vantage Ankle Fixed Bearing System....
Carlsmed will use $30 Million Series B funds to ramp commercialization of aprevo FDA-cleared personalized surgical devices....
Emmanuel Bonhomme will step in as Luigi Ferrari leaves to pursue new activities....
ORHub will enter the medical device market with biologics to regenerate cartilage and address degenerative disc disease and osteoarthritis....
Dave Demski, President and CEO, resigned after nearly 20 years with the company. Daniel T. Scavilla has been named as...